These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21492964)

  • 1. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.
    Gilley J; Seereeram A; Ando K; Mosely S; Andrews S; Kerschensteiner M; Misgeld T; Brion JP; Anderton B; Hanger DP; Coleman MP
    Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons.
    Rodríguez-Martín T; Pooler AM; Lau DHW; Mórotz GM; De Vos KJ; Gilley J; Coleman MP; Hanger DP
    Neurobiol Dis; 2016 Jan; 85():1-10. PubMed ID: 26459111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
    Adalbert R; Milde S; Durrant C; Ando K; Stygelbout V; Yilmaz Z; Gould S; Brion JP; Coleman MP
    Neurobiol Aging; 2018 Aug; 68():68-75. PubMed ID: 29729423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
    Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
    J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.
    Higuchi M; Zhang B; Forman MS; Yoshiyama Y; Trojanowski JQ; Lee VM
    J Neurosci; 2005 Oct; 25(41):9434-43. PubMed ID: 16221853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.
    Yotsumoto K; Saito T; Asada A; Oikawa T; Kimura T; Uchida C; Ishiguro K; Uchida T; Hasegawa M; Hisanaga SI
    J Biol Chem; 2009 Jun; 284(25):16840-16847. PubMed ID: 19401603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
    Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei.
    Dutschmann M; Menuet C; Stettner GM; Gestreau C; Borghgraef P; Devijver H; Gielis L; Hilaire G; Van Leuven F
    J Neurosci; 2010 Feb; 30(5):1810-21. PubMed ID: 20130190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
    Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
    J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
    Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
    Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia.
    Majid T; Ali YO; Venkitaramani DV; Jang MK; Lu HC; Pautler RG
    Neuroimage Clin; 2014; 4():711-7. PubMed ID: 24936422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
    Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
    J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
    Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
    Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of Tau-P301L transgenic mice reveals no cognitive impairments at 17 months of age.
    Kent BA; Heath CJ; Kim CH; Ahrens R; Fraser PE; St George-Hyslop P; Bussey TJ; Saksida LM
    Brain Behav; 2018 Jan; 8(1):e00896. PubMed ID: 29568692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.
    Lim J; Balastik M; Lee TH; Nakamura K; Liou YC; Sun A; Finn G; Pastorino L; Lee VM; Lu KP
    J Clin Invest; 2008 May; 118(5):1877-89. PubMed ID: 18431510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
    Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
    J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy.
    Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.